View Item 

Show simple item record

Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists

dc.contributor.authorEmanuel, Patrick O.
dc.contributor.authorAndea, Aleodor A.
dc.contributor.authorVidal, Claudia I.
dc.contributor.authorMissall, Tricia A.
dc.contributor.authorNovoa, Roberto A.
dc.contributor.authorBohlke, Angela K.
dc.contributor.authorHughes, Sarah R.
dc.contributor.authorHurley, Maria Y.
dc.contributor.authorKim, Jinah
dc.date.accessioned2018-11-20T15:36:00Z
dc.date.available2020-01-06T16:40:59Zen
dc.date.issued2018-11
dc.identifier.citationEmanuel, Patrick O.; Andea, Aleodor A.; Vidal, Claudia I.; Missall, Tricia A.; Novoa, Roberto A.; Bohlke, Angela K.; Hughes, Sarah R.; Hurley, Maria Y.; Kim, Jinah (2018). "Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists." Journal of Cutaneous Pathology 45(11): 839-846.
dc.identifier.issn0303-6987
dc.identifier.issn1600-0560
dc.identifier.urihttps://hdl.handle.net/2027.42/146490
dc.publisherBlackwell Publishing Ltd
dc.publisherWiley Periodicals, Inc.
dc.subject.othersingle‐nucleotide polymorphism
dc.subject.otherchain reaction
dc.subject.otherfluorescence in situ hybridization
dc.subject.othergene expression profiling by quantitative reverse transcription polymerase
dc.subject.othermelanocytic lesions
dc.subject.othercomparative genomic hybridization
dc.titleEvidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDermatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146490/1/cup13327_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146490/2/cup13327-sup-0001-AppendixS1.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/146490/3/cup13327.pdf
dc.identifier.doi10.1111/cup.13327
dc.identifier.sourceJournal of Cutaneous Pathology
dc.identifier.citedreferenceAl‐Rohil RN, Curry JL, Torres‐Cabala CA, et al. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol. 2016; 53: 73 ‐ 81.
dc.identifier.citedreferenceDeMarchis EH, Swetter SM, Jennings CD, Kim J. Fluorescence in situ hybridization analysis of atypical melanocytic proliferations and melanoma in young patients. Pediatr Dermatol. 2014; 31 ( 5 ): 561 ‐ 569.
dc.identifier.citedreferenceDika E, Fanti PA, Fiorentino M, et al. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis. Melanoma Res. 2015; 25 ( 4 ): 295 ‐ 301.
dc.identifier.citedreferenceGerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009; 33 ( 8 ): 1146 ‐ 1156.
dc.identifier.citedreferenceMorey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by four‐colour fluorescence in situ hybridisation. Pathology. 2009; 41 ( 4 ): 383 ‐ 387.
dc.identifier.citedreferenceGerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol. 2009; 33 ( 12 ): 1783 ‐ 1788.
dc.identifier.citedreferenceZimmermann AK, Hirschmann A, Pfeiffer D, Paredes BE, Diebold J. FISH analysis for diagnostic evaluation of challenging melanocytic lesions. Histol Histopathol. 2010; 25 ( 9 ): 1139 ‐ 1147.
dc.identifier.citedreferenceGerami P, Barnhill RL, Beilfuss BA, LeBoit P, Schneider P, Guitart J. Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH. Am J Surg Pathol. 2010; 34 ( 6 ): 816 ‐ 821.
dc.identifier.citedreferenceMoore MW, Gasparini R. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions. Diagn Pathol. 2011; 6: 76.
dc.identifier.citedreferenceVergier B, Prochazkova‐Carlotti M, de la Fouchardière A, et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol. 2011; 24 ( 5 ): 613 ‐ 623.
dc.identifier.citedreferenceZembowicz A, Yang SE, Kafanas A, Lyle SR. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. Arch Pathol Lab Med. 2012; 136 ( 12 ): 1571 ‐ 1579.
dc.identifier.citedreferenceTetzlaff MT, Wang WL, Milless TL, et al. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluores cence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses. Am J Surg Pathol. 2013; 37 ( 12 ): 1783 ‐ 1796.
dc.identifier.citedreferenceNorth JP, Garrido MC, Kolaitis NA, LeBoit PE, McCalmont TH, Bastian BC. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. Am J Surg Pathol. 2014; 38 ( 6 ): 824 ‐ 831.
dc.identifier.citedreferenceBusam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J Cutan Pathol. 2010; 37 ( 2 ): 196 ‐ 203.
dc.identifier.citedreferencePouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P. Distinguishing epithelioid blue nevus from blue nevus‐like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol. 2009; 33 ( 9 ): 1396 ‐ 1400.
dc.identifier.citedreferencePouryazdanparast P, Haghighat Z, Beilfuss BA, Guitart J, Gerami P. Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings. Am J Surg Pathol. 2011; 35 ( 9 ): 1405 ‐ 1412.
dc.identifier.citedreferenceRequena C, Rubio L, Traves V, et al. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma. Histopathology. 2012; 61 ( 5 ): 899 ‐ 909.
dc.identifier.citedreferenceDalton SR, Gerami P, Kolaitis NA, et al. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol. 2010; 34 ( 2 ): 231 ‐ 237.
dc.identifier.citedreferenceGerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol. 2011; 38 ( 4 ): 329 ‐ 334.
dc.identifier.citedreferenceHossain D, Qian J, Adupe J, Drewnowska K, Bostwick DG. Differentiation of melanoma and benign nevi by fluorescence in‐situ hybridization. Melanoma Res. 2011; 21 ( 5 ): 426 ‐ 430.
dc.identifier.citedreferenceGerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012; 36 ( 6 ): 808 ‐ 817.
dc.identifier.citedreferenceGammon B, Beilfuss B, Guitart J, Gerami P. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol. 2012; 36 ( 1 ): 81 ‐ 88.
dc.identifier.citedreferenceNorth JP, Vetto JT, Murali R, White KP, White CR Jr, Bastian BC. Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol. 2011; 35 ( 8 ): 1146 ‐ 1150.
dc.identifier.citedreferenceGerami P, Jewell SS, Pouryazdanparast P, et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn. 2011; 13 ( 3 ): 352 ‐ 358.
dc.identifier.citedreferenceGerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013; 37 ( 5 ): 676 ‐ 684.
dc.identifier.citedreferenceClarke LE, Flake DD, Busam K, et al. An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi. Cancer. 2017; 123 ( 4 ): 617 ‐ 628.
dc.identifier.citedreferenceMinca EC, Al‐Rohil RN, Wang M, et al. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions. Mod Pathol. 2016; 29 ( 8 ): 832 ‐ 843.
dc.identifier.citedreferenceCockerell CJ, Tschen J, Evans B, et al. The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists. Medicine. 2016; 95 ( 40 ): e4887.
dc.identifier.citedreferenceVidal CI, Armbrect EA, Andea AA, et al. Appropriate use criteria in dermatopathology: initial recommendations from the American Society of Dermatopathology. J Cutan Pathol. 2018; 45: 563 ‐ 580.
dc.identifier.citedreferenceWang Y, Carlton VE, Karlin‐Neumann G, et al. High quality copy number and genotype data from FFPE samples using molecular inversion probe (MIP) microarrays. BMC Med Genomics. 2009; 2: 8.
dc.identifier.citedreferenceChandler WM, Rowe LR, Florell SR, Jahromi MS, Schiffman JD, South ST. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements. Arch Pathol Lab Med. 2012; 136 ( 8 ): 947 ‐ 955.
dc.identifier.citedreferenceBastian BC, LeBoit PE, Hamm H, Bröcker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998; 58 ( 10 ): 2170 ‐ 2175.
dc.identifier.citedreferenceBastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003; 163 ( 5 ): 1765 ‐ 1770.
dc.identifier.citedreferenceBastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999; 113 ( 6 ): 1065 ‐ 1069.
dc.identifier.citedreferenceBastian BC, Xiong J, Frieden IJ, et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol. 2002; 161 ( 4 ): 1163 ‐ 1169.
dc.identifier.citedreferenceKallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992; 258: 818 ‐ 821.
dc.identifier.citedreferenceWeiss MM, Hermsen MA, Meijer GA, et al. Comparative genomic hybridisation. Mol Pathol. 1999; 52 ( 5 ): 243 ‐ 251.
dc.identifier.citedreferenceWang L, Rao M, Fang Y, et al. A genome‐wide high‐resolution array‐CGH analysis of cutaneous melanoma and comparison of array‐CGH to FISH in diagnostic evaluation. J Mol Diagn. 2013; 15 ( 5 ): 581 ‐ 591.
dc.identifier.citedreferenceNorth JP, Vemula SS, Bastian BC. Chromosomal copy number analysis in melanoma diagnostics. Methods Mol Biol. 2014; 1102: 199 ‐ 226.
dc.identifier.citedreferenceHarvell JD, Bastian BC, LeBoit PE. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol. 2002; 26 ( 5 ): 654 ‐ 661.
dc.identifier.citedreferenceMcCalmont TH. Gone FISHing. J Cutan Pathol. 2010; 37 ( 2 ): 193 ‐ 195.
dc.identifier.citedreferenceLivak KJ, Schmittgen TD. Analysis of relative gene expression data using real‐time quantitative PCR and the 2(−Delta Delta C[T]) method. Methods. 2001; 25 ( 4 ): 402 ‐ 408.
dc.identifier.citedreferenceClarke LE, Warf MB, Flake DD 2nd, et al. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015; 42 ( 4 ): 244 ‐ 252.
dc.identifier.citedreferenceNamiki T, Yanagawa S, Izumo T, et al. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet Cytogenet. 2005; 157 ( 1 ): 1 ‐ 11.
dc.identifier.citedreferencevan Dijk M, Sprenger S, Rombout P, et al. Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization. Genes Chromosomes Cancer. 2003; 36 ( 2 ): 151 ‐ 158.
dc.identifier.citedreferenceKutzner H, Metzler G, Argenyi Z, et al. Histological and genetic evidence for a variant of superficial spreading melanoma composed predominantly of large nests. Mod Pathol. 2012; 25 ( 6 ): 838 ‐ 845.
dc.identifier.citedreferenceVincek V, Xu S, Fan YS. Comparative genome hybridization analysis of laser‐capture microdissected in situ melanoma. J Cutan Pathol. 2010; 37 ( 1 ): 3 ‐ 7.
dc.identifier.citedreferenceGaiser T, Kutzner H, Palmedo G, et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long‐term follow up. Mod Pathol. 2010; 23 ( 3 ): 413 ‐ 419.
dc.identifier.citedreferenceHirsch D, Kemmerling R, Davis S, et al. Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res. 2013; 73 ( 5 ): 1454 ‐ 1460.
dc.identifier.citedreferenceChan MP, Andea AA, Harms PW, et al. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus. Mod Pathol. 2016; 29 ( 3 ): 227 ‐ 239.
dc.identifier.citedreferenceMagro CM, Abraham R, Guo R, et al. Deep penetrating nevus‐like borderline tumors: a unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics. Eur J Dermatol. 2014; 24 ( 5 ): 594 ‐ 602.
dc.identifier.citedreferenceAli L, Helm T, Cheney R, et al. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms. Int J Clin Exp Pathol. 2010; 3 ( 6 ): 593 ‐ 599.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cup13327_am.pdf
Size:
7.215MB
Format:
PDF
View/Open
Name:
cup13327-sup-0001-AppendixS1.pdf
Size:
382.5KB
Format:
PDF
View/Open
Name:
cup13327.pdf
Size:
2.198MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.